Profarma (B3: PFRM3) dividends paid
Profarma paid BRL 76.7m in dividends in fiscal 2025, 40.5% more than in fiscal 2024 (BRL 54.6m). That was 64.5% of its net income for the year. It is the total cash paid according to its cash flow statement, not the dividend per share.
Dividends paid by fiscal year
| Fiscal year | Dividends paid | Change | Payout ratio |
|---|---|---|---|
| 2025 | BRL 76.7m | +40.5% | 64.5% |
| 2024 | BRL 54.6m | +74.8% | 47.6% |
| 2023 | BRL 31.2m | — | 44.4% |
| 2021 | BRL 29.1m | — | 37.2% |
The figure for each fiscal year is the total cash paid in dividends according to the cash flow statement in the annual accounts. It is not the dividend per share and may include amounts paid to minority shareholders of subsidiaries. It covers closed fiscal years and is not a forecast. The change compares each fiscal year with the one before and is not shown when the amount paid is more than ten times the previous one. The payout ratio divides dividends paid by net income for the same fiscal year and is not calculated when net income was not positive. Figures are in millions of Brazilian reais.
Questions about the dividends of Profarma
- How much did Profarma pay in dividends in fiscal 2025?
- Profarma paid BRL 76.7m in dividends in fiscal 2025, according to its cash flow statement; in fiscal 2024 it paid BRL 54.6m.
- What share of its profit did Profarma pay out?
- In fiscal 2025 dividends paid were 64.5% of its net income, which was BRL 118.9m.
- In which year did Profarma pay the most in dividends?
- Of its last 4 fiscal years with the figure, fiscal 2025, with BRL 76.7m paid in dividends.
- Where do the figures for Profarma come from?
- From the annual financial statements (DFP) that Profarma files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual financial statements (DFP) that Profarma files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2021. More on Profarma: the Profarma page · annual accounts · revenue · net income.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.